|
FYTTD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.970270E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.03570000000864E-05 |
| Normal-vs-Stage2 |
4.682400E-03 |
| Normal-vs-Stage3 |
4.459500E-02 |
| Normal-vs-Stage4 |
3.558200E-02 |
| Stage1-vs-Stage2 |
8.453400E-01 |
| Stage1-vs-Stage3 |
4.412000E-01 |
| Stage1-vs-Stage4 |
8.549000E-01 |
| Stage2-vs-Stage3 |
6.647200E-01 |
| Stage2-vs-Stage4 |
9.657400E-01 |
| Stage3-vs-Stage4 |
7.765000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.90969999999524E-05 |
| Normal-vs-AfricanAmerican |
1.489580E-02 |
| Normal-vs-Asian |
6.806100E-02 |
| Caucasian-vs-AfricanAmerican |
2.834800E-01 |
| Caucasian-vs-Asian |
8.863400E-01 |
| AfricanAmerican-vs-Asian |
8.080200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.62050000000114E-05 |
| Normal-vs-Female |
4.146400E-01 |
| Male-vs-Female |
2.955700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.753400E-04 |
| Normal-vs-Extreme_Weight |
4.3113000000039E-05 |
| Normal-vs-Obese |
5.818200E-03 |
| Normal-vs-Extreme_Obese |
1.404350E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.460200E-01 |
| Normal_Weight-vs-Obese |
3.441800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.636000E-01 |
| Extreme_Weight-vs-Obese |
2.444800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.233800E-01 |
| Obese-vs-Extreme_Obese |
8.245800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.407800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.344500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.28579999999035E-05 |
| Normal-vs-Age(81-100Yrs) |
6.04319999999436E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.881200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.177600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.622500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.857800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.319600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.527200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.781300E-04 |
| Normal-VS-Type2 PRCC |
2.00340000000576E-06 |
| Normal-VS-KIRP CIMP |
5.943400E-01 |
| Normal-VS-Unclassified PRCC |
1.188370E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.702300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.314400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.824400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.352500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.331700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.956030E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.0761999997585E-07 |
| Normal-vs-N1 |
5.086100E-02 |
| Normal-vs-N2 |
4.793600E-02 |
| N0-vs-N1 |
1.357950E-02 |
| N0-vs-N2 |
8.010400E-01 |
| N1-vs-N2 |
4.017400E-01 |
|
|
